- Home
- FRSH vs RNA Comparison
FRSH vs RNA Comparison
Compare FRSH & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRSH
- RNA
- Stock Information
- Founded
- FRSH 2010
- RNA 2012
- Country
- FRSH United States
- RNA United States
- Employees
- FRSH N/A
- RNA N/A
- Industry
- FRSH EDP Services
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- FRSH Technology
- RNA Health Care
- Exchange
- FRSH Nasdaq
- RNA Nasdaq
- Market Cap
- FRSH 4.5B
- RNA 4.4B
- IPO Year
- FRSH 2021
- RNA 2020
- Fundamental
- Price
- FRSH $17.44
- RNA $28.92
- Analyst Decision
- FRSH Buy
- RNA Strong Buy
- Analyst Count
- FRSH 14
- RNA 10
- Target Price
- FRSH $19.36
- RNA $65.80
- AVG Volume (30 Days)
- FRSH 3.2M
- RNA 1.4M
- Earning Date
- FRSH 02-11-2025
- RNA 02-26-2025
- Dividend Yield
- FRSH N/A
- RNA N/A
- EPS Growth
- FRSH N/A
- RNA N/A
- EPS
- FRSH N/A
- RNA N/A
- Revenue
- FRSH $685,960,000.00
- RNA $10,117,000.00
- Revenue This Year
- FRSH $22.34
- RNA N/A
- Revenue Next Year
- FRSH $13.82
- RNA N/A
- P/E Ratio
- FRSH N/A
- RNA N/A
- Revenue Growth
- FRSH 20.45
- RNA N/A
- 52 Week Low
- FRSH $10.81
- RNA $9.93
- 52 Week High
- FRSH $23.30
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- FRSH 65.85
- RNA 37.85
- Support Level
- FRSH $15.29
- RNA $26.74
- Resistance Level
- FRSH $16.96
- RNA $31.06
- Average True Range (ATR)
- FRSH 0.53
- RNA 1.77
- MACD
- FRSH 0.12
- RNA 0.24
- Stochastic Oscillator
- FRSH 93.09
- RNA 37.85
About FRSH Freshworks Inc.
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.